Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence
- 1 August 2019
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 65 (1) , 111-118
Abstract
Background Factors associated with interval colorectal cancer (CRC) development in the inflammatory bowel disease (IBD) population remain unclear. Aims Among a cohort of patients with interval CRC, we aimed to evaluate IBD characteristics, colonoscopy quality indicators, and surveillance guideline adherence. Methods We performed a retrospective review of IBD- and non-IBD-associated interval CRCs diagnosed between January 2007 and December 2014 within a large US healthcare system. We evaluated risk factors for CRC among patients with IBD. We assessed adherence to surveillance guidelines according to the American Society for Gastrointestinal Endoscopy (IBD surveillance) and the US Multi-Society Task Force on Colorectal Cancer (polyp surveillance). We compared colonoscopy quality measures between patients with and without IBD. Results Among 5345 cases of colonic adenocarcinoma, we detected 15 IBD-associated cases of interval CRC and 230 non-IBD-associated cases of interval CRC. Compared to patients without IBD, IBD patients were younger (54.5 vs. 70.4 years; p < 0.0001) and experienced a shorter interval between index colonoscopy and CRC diagnosis (20.7 vs. 35.1 months; p = 0.0009). Fifty three percent (8/15) of interval CRCs in IBD patients were detected within surveillance guidelines. All IBD patients with interval CRC detected after guideline surveillance interval had high-risk features, including active inflammation, previous low-grade or indefinite dysplasia, multiple pseudopolyps on index colonoscopy, or a first-degree relative with CRC. There were no differences in colonoscopy quality measures between patients with and without IBD. Conclusions This study stresses the importance of strict short-interval surveillance for IBD patients with high-risk features, including active inflammation on index colonoscopy.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (F32 DK115134, K23 DK099681)
- American Gastroenterological Association (HK)
This publication has 37 references indexed in Scilit:
- Impact of physician compliance with colonoscopy surveillance guidelines on interval colorectal cancerGastrointestinal Endoscopy, 2017
- Low-Grade Dysplasia in Ulcerative Colitis: Risk Factors for Developing High-Grade Dysplasia or Colorectal CancerAmerican Journal of Gastroenterology, 2015
- European evidence based consensus for endoscopy in inflammatory bowel diseaseJournal of Crohn's and Colitis, 2013
- AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel DiseaseGastroenterology, 2010
- Colon CancerJournal of the National Comprehensive Cancer Network, 2009
- Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2009
- Rare CpG Island Methylator Phenotype in Ulcerative Colitis–Associated NeoplasiasGastroenterology, 2007
- Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitisGastroenterology, 2004
- Cancer risk in patients with inflammatory bowel diseaseCancer, 2001
- Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis.Gut, 1994